Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 30, 2025 | (FY)Mar 30, 2024 | (FY)Mar 30, 2023 | (FY)Mar 30, 2022 | (FY)Mar 30, 2021 | (FY)Mar 30, 2020 | (FY)Mar 30, 2019 | (FY)Mar 30, 2018 | (FY)Mar 30, 2017 | (FY)Mar 30, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -8.62%21.85M | 21.88%23.91M | 71.39%19.62M | 48.62%11.45M | 76.22%7.7M | 14.49%4.37M | 12.26%3.82M | -57.83%3.4M | 62.03%8.06M | 161.92%4.98M |
| Operating revenue | -8.62%21.85M | 21.88%23.91M | 71.39%19.62M | 48.62%11.45M | 76.22%7.7M | 14.49%4.37M | 12.26%3.82M | -57.83%3.4M | 62.03%8.06M | 161.92%4.98M |
| Cost of revenue | ||||||||||
| Gross profit | -8.62%21.85M | 21.88%23.91M | 71.39%19.62M | 48.62%11.45M | 76.22%7.7M | 14.49%4.37M | 12.26%3.82M | -57.83%3.4M | 62.03%8.06M | 161.92%4.98M |
| Operating expense | -7.81%55.95M | 14.34%60.69M | 57.82%53.08M | 36.58%33.63M | 1.72%24.62M | 4.53%24.21M | -6.80%23.16M | -18.58%24.85M | 33.43%30.51M | 53.89%22.87M |
| Selling and administrative expenses | -37.37%23.33M | 3.35%37.25M | 55.79%36.04M | 65.33%23.13M | -2.70%13.99M | -11.50%14.38M | 6.75%16.25M | -13.59%15.22M | 52.63%17.62M | 45.79%11.54M |
| -Selling and marketing expense | -31.50%17.53M | 1.86%25.59M | 467.24%25.12M | -51.87%4.43M | 7.36%9.2M | 4.07%8.57M | -12.72%8.24M | 390.72%9.44M | 88.18%1.92M | 6.61%1.02M |
| -General and administrative expense | -50.25%5.8M | 6.77%11.66M | -41.64%10.92M | 290.48%18.7M | -17.56%4.79M | -27.50%5.81M | 38.48%8.01M | -63.12%5.79M | 49.18%15.69M | 51.19%10.52M |
| Research and development costs | 165.15%14.63M | 55.26%5.52M | 43.83%3.55M | -46.10%2.47M | 17.06%4.58M | 117.80%3.92M | -58.99%1.8M | 30.36%4.38M | -24.30%3.36M | --4.44M |
| Depreciation amortization depletion | -14.64%2.34M | 314.18%2.75M | 71.76%663K | 3.21%386K | -32.85%374K | 77.39%557K | -37.70%314K | -7.00%504K | 7.06%541.94K | 10.33%506.2K |
| -Depreciation and amortization | -14.64%2.34M | 314.18%2.75M | 71.76%663K | 3.21%386K | -32.85%374K | 77.39%557K | -37.70%314K | -7.00%504K | 7.06%541.94K | 10.33%506.2K |
| Provision for doubtful accounts | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --3.25M | ---- |
| Other operating expenses | 3.07%15.65M | 18.41%15.18M | 67.78%12.82M | 34.69%7.64M | 6.00%5.67M | 11.64%5.35M | 1.27%4.79M | -17.61%4.73M | -9.93%5.75M | -1.64%6.38M |
| Operating profit | 7.28%-34.1M | -9.93%-36.78M | -50.82%-33.46M | -31.11%-22.19M | 14.69%-16.92M | -2.57%-19.84M | 9.82%-19.34M | 4.49%-21.45M | -25.48%-22.45M | -38.06%-17.89M |
| Net non-operating interest income (expenses) | -44.61%1.89M | 24.16%3.41M | 422.43%2.75M | 68.59%526K | 40.54%312K | -31.27%222K | 39.83%323K | -7.08%231K | -67.38%248.6K | 49.58%762.18K |
| Non-operating interest income | -43.93%1.93M | 24.34%3.43M | 402.91%2.76M | 56.41%549K | 40.96%351K | -22.91%249K | 39.83%323K | -7.08%231K | -67.38%248.6K | 49.58%762.18K |
| Total other finance cost | 66.67%35K | 61.54%21K | -43.48%13K | -41.03%23K | 44.44%39K | --27K | ---- | ---- | ---- | ---- |
| Other net income (expenses) | -56.73%845K | -47.88%1.95M | 98.89%3.75M | -21.07%1.88M | 312.26%2.39M | -41.46%579K | -27.86%989K | 12.00%1.37M | -15.90%1.22M | 19.06%1.46M |
| Other non-operating income (expenses) | -56.73%845K | -47.88%1.95M | 98.89%3.75M | -21.07%1.88M | 312.26%2.39M | -41.46%579K | -27.86%989K | 12.00%1.37M | -15.90%1.22M | 19.06%1.46M |
| Income before tax | -1.36%-29.94M | -9.53%-29.54M | -36.27%-26.97M | -39.13%-19.79M | 24.69%-14.22M | -5.46%-18.89M | 8.83%-17.91M | 6.37%-19.64M | -33.83%-20.98M | -46.11%-15.68M |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 9K | 0 | 0 | 0 |
| Earnings from equity interest net of tax | ||||||||||
| Net income | -1.36%-29.94M | -9.53%-29.54M | -36.27%-26.97M | -39.13%-19.79M | 24.69%-14.22M | -5.40%-18.89M | 8.79%-17.92M | 6.37%-19.64M | -33.83%-20.98M | -46.11%-15.68M |
| Net income continuous operations | -1.36%-29.94M | -9.53%-29.54M | -36.27%-26.97M | -39.13%-19.79M | 24.69%-14.22M | -5.40%-18.89M | 8.79%-17.92M | 6.37%-19.64M | -33.83%-20.98M | -46.11%-15.68M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -1.36%-29.94M | -9.53%-29.54M | -36.27%-26.97M | -39.13%-19.79M | 24.69%-14.22M | -5.40%-18.89M | 8.79%-17.92M | 6.37%-19.64M | -33.83%-20.98M | -46.11%-15.68M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -1.36%-29.94M | -9.53%-29.54M | -36.27%-26.97M | -39.13%-19.79M | 24.69%-14.22M | -5.40%-18.89M | 8.79%-17.92M | 6.37%-19.64M | -33.83%-20.98M | -46.11%-15.68M |
| Diluted earnings per share | -2.78%-0.037 | -9.09%-0.036 | -26.92%-0.033 | -30.00%-0.026 | 37.50%-0.02 | 7.65%-0.032 | 17.78%-0.0347 | 17.83%-0.0421 | -27.91%-0.0513 | -31.55%-0.0401 |
| Basic earnings per share | -2.78%-0.037 | -9.09%-0.036 | -26.92%-0.033 | -30.00%-0.026 | 37.50%-0.02 | 7.65%-0.032 | 17.78%-0.0347 | 17.83%-0.0421 | -27.91%-0.0513 | -31.55%-0.0401 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |